Sep 11, 2018 Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 ProgramBURNABY, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused ... read morePublished on 2018-09-11